Intellia Therapeutics, Inc. (NTLA)
12.55
-0.29
(-2.26%)
USD |
NASDAQ |
Aug 24, 16:00
12.55
0.00 (0.00%)
After-Hours: 19:54
Intellia Therapeutics Shareholders Equity (Quarterly) : 727.71M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 727.71M |
| March 31, 2026 | 620.94M |
| December 31, 2025 | 671.39M |
| September 30, 2025 | 748.42M |
| June 30, 2025 | 715.26M |
| March 31, 2025 | 779.92M |
| December 31, 2024 | 871.96M |
| September 30, 2024 | 962.62M |
| June 30, 2024 | 971.06M |
| March 31, 2024 | 1.036B |
| December 31, 2023 | 1.050B |
| September 30, 2023 | 1.037B |
| June 30, 2023 | 1.105B |
| March 31, 2023 | 1.191B |
| December 31, 2022 | 1.236B |
| September 30, 2022 | 824.95M |
| June 30, 2022 | 880.55M |
| March 31, 2022 | 953.75M |
| December 31, 2021 | 1.040B |
| September 30, 2021 | 1.107B |
| June 30, 2021 | 494.81M |
| Date | Value |
|---|---|
| March 31, 2021 | 545.87M |
| December 31, 2020 | 527.07M |
| September 30, 2020 | 329.62M |
| June 30, 2020 | 351.59M |
| March 31, 2020 | 247.76M |
| December 31, 2019 | 269.88M |
| September 30, 2019 | 275.65M |
| June 30, 2019 | 276.87M |
| March 31, 2019 | 264.34M |
| December 31, 2018 | 277.92M |
| September 30, 2018 | 263.27M |
| June 30, 2018 | 279.34M |
| March 31, 2018 | 295.50M |
| December 31, 2017 | 300.60M |
| September 30, 2017 | 175.85M |
| June 30, 2017 | 187.58M |
| March 31, 2017 | 199.88M |
| December 31, 2016 | 209.84M |
| September 30, 2016 | 218.12M |
| June 30, 2016 | 223.60M |
| March 31, 2016 | 61.48M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.067B |
| Twist Bioscience Corp. | 445.74M |
| Tenaya Therapeutics, Inc. | 69.41M |
| Moderna, Inc. | 6.761B |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 857.16M |
| Total Liabilities (Quarterly) | 129.46M |
| Debt to Equity Ratio | 0.1009 |
| Current Ratio | 6.648 |
| Net Debt Paydown Yield | 0.39% |